We used in situ hybridization to detect hepatitis C virus (HCV) infection of peripheral blood mononuclear cells (PBMNC) from 11 patients with chronic active hepatitis. Using 36S-labeled HCV-RNA probe, HCV-RNA-positive and -negative strands were observed in unstimulated PBMNC from three patients, all of whom were receiving immunosuppressive drugs after orthotopic liver transplantation (OLT). HCV-RNA sequences were also identified in PBMNC from three patients who were not undergoing irn-H EPATITIS C VIRUS (HCV) is a small RNA virus responsible for the vast majority of posttransfusional and sporadic cases of non-A, non-B hepatitis. Its structure and pathogenicity are still under investigation.' Infection becomes chronic in more than 50% of cases, but the mechanism of viral persistence and the cellular tropism of HCV are still unclear and there is no cell culture system available.* There is also little information on the involvement of peripheral blood mononuclear cells (PBMNC) during HCV infection, but it has recently been shown that HCV-RNA can be detected by polymerase chain reaction (PCR) in PBMNC,3v4 although contamination by serum particles during cell isolation cannot be completely ruled out.
munosuppression, after stimulation with either phytohemagglutinin (PHA) or pokeweed mitogen (PWM). In contrast, HCV-RNA was not found in the remaining five patients, who had not undergone OLT and whose cells were not stimulated with mitogens. These results show that mononuclear cells can be infected by HCV and that mitogenic stimulation of infected cells increases HCV-RNA replication.
0 1994 by The American Society of Hematology. cells were then separated by Ficoll-Hypaque density gradient centrifugation, washed three times, and resuspended in RPMI. The degree of separation was determined by fluorescence activated cell sorter analysis (FACSstar, Becton Dickinson) using monoclonal antibodies (CD3, CD16, CD19; Immunotech SA, France). The cells (0.5 to 0.7 X 1 06/mL) were then attached to gelatin-pretreated slides by cytocentrifugation. After air-drying, the cells(-10,000 per slide) were fixed with 4% paraformaldehyde (PFA) for 10 minutes, washed three times in phosphate-buffered saline (PBS), and dehydrated through a graded series ofethanols (30% to 100%). The slides were stored at -20°C.
As patients no. 6 through 8 (Table 1) had marked iymphocytopenia, total PBMNC were resuspended at a density of 0.5 to 0.7 X 106/mL in RPMI for cytocentrifugation and fixation as described earlier. In cases no. 9 through I 1 ( Table 1) total PBMNC were cultured with phytohemagglutinin (PHA; 4 pg/106 cells/mL) and pokeweed mitogen (PWM; 50 pL/106 cells/mL, GIBCO, Grand Island, NY). PHA essentially stimulates T lymphocytes, while PWM essentially stimulates B lymphocytes. After 48 hours of incubation, the cells were pelletized, washed, and resuspended at a density 0.5 to 0.7 X 106/mL in RPMI for cytocentrifugation and fixation.
Preparation of probes. We used cDNA corresponding to the 5' noncoding region of HCV-RNA (259 bp), which is highly conserved among different viral isolates. This cDNA was subcloned into the Bluescript SK plasmid (Stratagene, San Diego, CA). Antisense RNA was transcribed by T7 RNA polymerase (Pharmacia) after plasmid linearization with BamHI (Pharmacia). To prepare the sense probe, we used T, RNA polymerase (Pharmacia) after linearization with EcoRI (Boehringer, Mannheim, Germany). The Bluescript vector without cDNA was used as a negative control. Highspecific activity RNA probes were synthetized using 35S uridine tri- phosphate (UTP specific activity, > 1,000 Ci/mmol; Amersham, UK) according to the supplier's recommendations. Probe length was reduced to a mean size of approximately 50 nucleotides by alkali hydrolysis, and unincorporated nucleotides were removed by gel filtration on G75 sephadex. After precipitation, the probe was redissolved in a hybridization buffer (50% deionized formamide, 0.3 mol/L NaCI, 20 mmol/L Tris-HCI, pH 7.4, 5 mmol/L EDTA, 10 mmol/L NaPO,, pH 8. 10% dextran sulfate, 1X Denhardt's solution, and 50 pg/mL total yeast RNA) at a final concentration of 500,000 cpm/20 pL and stored at -2o'C.
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In situ hybridization. The slides were rinsed in a 0.85% saline solution for 5 minutes and postfixed in freshly prepared 4% PFA for 20 minutes. They were then rinsed twice in PBS for 5 minutes, and the cells digested with proteinase K (Merck, France; 10 pg/mL for 7 minutes). The slides were rinsed in PBS for 5 minutes, refixed in 4% PFA for 5 minutes, dipped in distilled water, and acetylated in a 0.09-mol/L solution of triethanolamine with acetic anhydride ( l / 400 vol/vol, 10 minutes). They were then rinsed in PBS and 0.85% saline for 5 minutes each, dehydrated through a series of ethanol (30% to loo%), and allowed to dry for at least 2 hours before hybridization. The probe was denatured for 2 minutes at 8WC, then applied to the slides, which were covered with a siliconized coverslip. Hybridization was performed at 52°C for 16 hours in a humid chamber.
The coverslips were gently floated off in a 5X SSC buffer (1 X SSC = 0.15 mol/L NaCI, 0.0 15 mol/L sodium citrate) and 10 mmol/L dithiotreitol at 42°C followed by a stringent wash at 60'C in 50% deionized formamide, 2X SSC, and 0.1 mol/L dithiotreitol. The slides were then rinsed in a washing buffer, and unhybridized probe was digested with RNase A (20 pg/mL) and T, (2 pg/mL; Boehringer) in washing buffer for 30 minutes at 37°C. After washes at 42°C in 2X SSC, 0% SSC, and 0.1 X SSC (1 5 minutes each), the slides were dehydrated in a series of ethanols containing 0.3 mol/L of ammonium acetate. The slides were exposed for 10 to 15 days at 4°C using Kodak NTB2 emulsion (Eastman Kodak, Rochester, NY). The slides were counterstained with Harris hematoxylin.
RESULTS
We have examined PBMNC of 1 1 patients with chronic active hepatitis C ( Table 1) . For three patients, the samples were obtained during the follow-up after orthotopic liver transplantation (OLT).
All I 1 PBMNC samples were first examined without mitogenic cell stimulation. HCV-RNA molecules were found in three samples ( Table 2) , corresponding to the OLT recipients. An antisense probe that detects positive HCV-RNA strands gave signals in all three of these cases (Fig 1A and  B) , while an HCV-RNA sense probe that detects negative strands gave signals in two cases (Fig IC and D) . PBMNC from three of the negative patients were also examined after stimulation with PHA and PWM; positive HCV-RNAs strands were found in all three, and negative HCV-RNA strands in two, regardless of the mitogen used. No signals were detected in PBMNC from the remaining five patients ( Table 2 , patients no. 1 through 5), who had not undergone liver transplantation and whose cells were not exposed to mitogen.
The proportion of positively labeled cells approximated 0.01% to 0.039' 0, although it reached 0.3% in one case with the antisense probe after stimulation with PHA ( Table 2 , patient no. 1 1 ; Fig 2A through E) . There was also a slightly but not significantly higher proportion of labeled cells after mitogenic stimulation with PHA than with PWM. As labeled cells were usually entirely covered by silver grains, it was impossible to distinguish between nuclear and/or cytoplasmic labeling (Fig 2E) , or to compare the labeling intensity with the antisense and sense probes; however, there was an apparent difference in favor of the antisense probe.
To check the specificity of the signals obtained in our experimental conditions, several controls were used. PBMNC from four healthy anti-HCV-negative blood donors showed no labeling when hybridized with the HCV-RNA antisense or sense probes. Two of them were also studied after stimulation with PHA and with PWM. These two samples showed no labeling with HCV-RNA antisense or sense probes ( Fig  2F) . Similarly, a cDNA-free 35S-labeled Bluescript SK plasmid probe, also used as a negative control, showed no hybridization with any of the 1 1 PBMNC samples (Fig 1 E and  F) . Liver tissue sections from HCV-positive patients containing HCV-RNAs detected by PCR were used as positive controls. Using both HCV antisense and sense probes, spe- cific signals were observed in scattered hepatocytes and in cells of the inflammatory infiltrates, whereas negative control tissue was unlabeled' (data not shown).
DISCUSSION
This study clearly demonstrates that HCV-RNA sequences can be detected in PBMNC from patients on immunosuppressive therapy (ie, after OLT). and after in vitro mitogenic stimulation. Based on PCR results, it has been previously suggested that HCV infects PBMNC.3 but in these experiments, contamination by infected serum particles during cell preparation could not be ruled out completely. Although one samplecontained 0.3% oflabeled cells after PHA stimulation, with the HCV antisense probe, labeled cells were generally present at very low frequency (0.01% to 0.03%). This range of values is in keeping with that reported in PBMNC from HIV-infected patients using HIV-RNA probe (0.001% to O.OI%).x Similarly, less than 0.03% of PBMNC from calves infected with bovine immunodeficiency-like virus contain the viral RNA.9 In contrast, using in situ hybridization. 1% to 10% of mononuclear cells from hepatitis B virus (HBV)-infected patients were found to contain HBV-DNA sequences.'" We only detected positive signals with unstimulated PBMNC from the three OLT recipients ( Table 2) . probably because of the drug-induced immunosuppression in these patients. Interestingly. HCV-RNAs were previously found either in PBMNC by means of PCR. or in inflammatory infiltrates ofthe liver by in situ hybridization. only in HCVpositive patients with immunodeficiency caused by HIV coinfection, a clinical situation with increased HTV viremia 3. 5 These results are in parallel to those obtained with woodchuck hepatitis virus (WHV): an increase in WHV-DNA replication was found in PBMNC of infected animals after lipopolysaccharide stimulation.'' It has also recently been reported that viral replication can be increased by PHA stimulation in HBV-infected PBMNC." The detection of infected cells with the HCV sense probe that recognizes HCV-RNA-negative strands confirms our previous findings in liver tissue.' Negative RNA molecules are probably intermediates in the replication ofthe HCV genome. In the Flmiviruse.~, negative RNA strands indeed serve as templates during replication. and as HCV is related to Fhvivirtlscs. it can be supposed that HCV follows the same replicative pattern. Using PCR, it has been shown in the liver and in the serum that the number of negative strands is usu- ally I O to 100 times lower than the number of positive strand^.^ In the present study, we found only a slight difference in the density of silver grains with the sense and antisense probes. but it was in favor of the antisense probe (which detects positively stranded HCV-RNA molecules).
We also found a slightly higher proportion of labeled cells after stimulation with PHA than with PWM (0.03% and 0.01%. respectively), but were unable to identify clearly which subpopulations of PBMNC were infected by HCV. This was due to the low number of cells disposed to perform theexperiments. Thisquestion could be investigated further by means of in situ PCR combined with FACS selection after antibody labeling.'3 However, the fact that cells were labeled after stimulation with PHA and PWM suggests that T and B lymphocytes are both infected. This can be correlated with data presented recently by Zignego et al, who found that HCV-RNAs were detected only in T and B lymphocytes in some cases by means of PCR. but not in the monocyte macrophage fraction.' Our results are also consistent with the recent demonstration that the human lymphocytic cell line MOLT4 can be infected by HCV.I4 However, it is noteworthy that a recent report suggested that the HCV capsid antigen might be detected in some HCV-positive patients in the circulating monocytes." 
